Clinical Trial Update: Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® [NA]

View source ↗

Summary

A Phase IV trial update for breast brachytherapy using Mammosite-Ml in breast cancer and ductal carcinoma in situ has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• Mammosite-Ml

Snippet

Sponsor: Mercy Research | Conditions: Breast Cancer, Ductal Carcinoma in Situ | NA | Status: COMPLETED | Results posted: 2021-07-15